PROCEPT BioRobotics Corp PRCT
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Securities Fraud Investigation Into PROCEPT BioRobotics Corporation (PRCT) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
-
PROCEPT BioRobotics Corporation (PRCT) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
-
Securities Fraud Investigation Into PROCEPT BioRobotics Corporation (PRCT) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
-
Wall Street short sellers have been crushed in 2025. Better days might be coming.
Trading Information
- Previous Close Price
- $19.15
- Day Range
- $18.95–19.71
- 52-Week Range
- $18.06–62.17
- Bid/Ask
- $19.05 / $19.09
- Shares Outstanding
- 56.92M
- Market Cap
- $1.10B
- Volume/Avg
- 651,359 / 2M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 3.33
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 888
Valuation
|
Metric
|
PRCT
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 3.13 |
Price/Sales | 3.33 |
Price/Cash Flow | — |
Price/Earnings
PRCT
Financial Strength
|
Metric
|
PRCT
|
|---|---|
Quick Ratio | 5.37 |
Current Ratio | 6.73 |
Interest Coverage | −30.97 |
Quick Ratio
PRCT
Profitability
|
Metric
|
PRCT
|
|---|---|
Return on Assets (Normalized) | −10.03% |
Return on Equity (Normalized) | −13.63% |
Return on Invested Capital (Normalized) | −12.76% |
Return on Assets
PRCT
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|>@%kw^ | LOCK|ppM$L | $155B | |||
| Stryker Corp
SYK
| LOCK|@%nq&h@ | LOCK|y$R | $121B | |||
| Medtronic PLC
MDT
| LOCK|F<W>D^ | LOCK|LgSLs | $103B | |||
| Boston Scientific Corp
BSX
| LOCK|csn&Ndx | LOCK|Sc>hC | $64B | |||
| Edwards Lifesciences Corp
EW
| LOCK|XL%nr?Q | LOCK|pH#l | $50B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|k@Y$k?w | LOCK|<r | $29B | |||
| DexCom Inc
DXCM
| LOCK|%>M>>VF | LOCK|D!CnQ | $28B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|Nv | LOCK|V< | $26B | |||
| Steris PLC
STE
| LOCK|kft^b? | LOCK|>JM^ | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|!YW<^>< | LOCK|T& | $17B |
United States